Combustible down by 3.3%, Altria Q1 Earnings Says

Business by Ellesmere Zhu
Apr.27.2023
Combustible down by 3.3%, Altria Q1 Earnings Says
On April 27th at 9 a.m. ET, Altria Group announced its Q1 2023 financial results. According to GAAP, Altria's net revenue for Q1 2023 was $7.19 billion, a 2.9% decrease YoY. CEO thinks highly of the yield of next-generation products, as Altria just acquired NJOY.

On April 27th at 9 a.m. ET, Altria Group announced its Q1 2023 financial results. According to GAAP, Altria's net revenue for Q1 2023 was $7.19 billion, a 2.9% decrease YoY; revenue excluding excise taxes was $4.76 billion, a 1.2% decrease YoY. The reported tax rate was 27.9%, up 1.2 percentage points from the same period last year, while the adjusted tax rate was 25.0%, down 0.1 percentage points YoY. Adjusted earnings per share were $1.18, a 5.4% increase YoY, while reported earnings per share were $1.00, a 7.4% decrease YoY.

 

Altria CEO Billy Gifford said the company had a strong start with robust adjusted earnings per share growth of 5.4% in the challenging macroeconomic environment.

 

Oral tobacco products performed well 

Altria reported growth in shipment volume and market share for its oral tobacco brand on! In Q1 2023, on! shipments reached 25.2 million boxes, up 37.7% YoY, and its market share increased to 6.5%.

 

Combustible down by 3.3%, Altria Q1 Earnings Says

 

Furthermore, other oral tobacco products such as Copenhagen and Skoal also saw growth.

 

Combustible down by 3.3%, Altria Q1 Earnings Says

 

Call for flavored tobacco enforcement 

In November 2022, California officially banned flavored (and menthol) tobacco and e-cigarette products through a referendum. Altria said it actively followed the policy, and stopped shipping related products to California, causing PM USA shipments to California to drop 12.8%. 

 

Combustible down by 3.3%, Altria Q1 Earnings Says

 

In the report, Altria mentioned that flavored tobacco products are still being sold at retail after the California flavor and menthol bans and called for increased enforcement.

 

Combustible down by 3.3%, Altria Q1 Earnings Says

 

Combustible revenue declines 

Financial results showed that Altria's traditional cigarette net revenue decreased by 3.3% YoY, primarily due to reduced shipment volume and increased promotional investments.

Combustible down by 3.3%, Altria Q1 Earnings Says

 

2023 earnings guidance 

Altria also released its full-year 2023 earnings guidance in the report. The company reiterated its commitment to delivering adjusted earnings per share in the range of $4.98 to $5.13 for 2023, a 3% to 6% increase over the 2022 adjusted earnings per share. Altria noted that its 2023 full-year adjusted earnings per share guidance considered various scenarios, as the external environment is uncertain. The company will continue to monitor economic and policy factors, including high inflation, rising interest rates, global supply chain disruptions, and regulatory and legislative developments.
 

Combustible down by 3.3%, Altria Q1 Earnings Says

 

2028 corporate goals

Altria also announced its 2028 corporate goals in the earnings report. The company plans to achieve these goals through various measures, including mid-single-digit growth in adjusted earnings per share by 2028, a progressive dividend target with mid-single-digit dividend growth, maintaining a debt/EBITDA ratio of around 2.0, maintaining leadership in the U.S. tobacco market, and sustaining an adjusted net profit margin of over 60% for at least the next five years.

 

In addition, Altria plans to achieve growth targets in its U.S. smoke-free product portfolio, including at least a 35% increase in smoke-free product sales volume from 2022 and increasing smoke-free product net revenue from $2.6 billion in 2022 to $5 billion, with $2 billion coming from innovative smoke-free products. The company also plans to expand its competitiveness in international innovative smoke-free and non-nicotine products for long-term growth and expects to develop strategies for these growth areas within the next 12 months and is confident in the e-vapor sector. 

 

Combustible down by 3.3%, Altria Q1 Earnings Says

 

Although the recent acquisition of NJOY, a leading North American e-vapor company, was not included in this financial report, the CEO expressed optimism for NJOY's development under Altria, noting that "NJOY is the only cartridge-based e-cigarette product to have passed FDA's pre-market tobacco product application (PMTA)."

 

Altria has not repurchased any shares in Q1 2023 due to the timing of the NJOY transaction announcement. As of March 31, 2023, there is $1 billion remaining under the current share repurchase program, which is expected to be completed by December 31, 2023. Share repurchases depend on market conditions and other factors, and the program remains subject to the discretion of Altria's Board of Directors.

 

In summary, Altria Group's Q1 2023 financial results showcased a strong start to the year, with its smoke-free product portfolio and recent acquisition of NJOY being areas of growth and optimism. The company has outlined its 2023 earnings guidance and ambitious 2028 corporate goals, focusing on smoke-free products and international market expansion. Altria will continue to monitor external factors and developments that may impact its performance and adapt its strategies accordingly.

 

Also read:

Altria, Reynolds Initiated Battle over Menthol Cigarettes in New York
Altria and Juul Face Trial Over Teen Vaping Accusations

 

Source: Altria's Q1 Report

*This article is an original article of 2FIRSTS Technology Co., Ltd. The copyright and license rights belong to the company. Any entity or individual shall make link and credit 2FIRSTS when taking actions to copy, reprint or distribute the original article. The company retains the right to pursue its legal responsibility.

Exclusive | TPE 2026 Cools as Caution Deepens in the U.S. Vape Market
Exclusive | TPE 2026 Cools as Caution Deepens in the U.S. Vape Market
The show had become an important check-in point for Chinese manufacturers and brand owners looking for signs of change in the U.S. market after months of softer demand. Instead, participants said the event highlighted a more restrained mood: traffic in the vape section was uneven, standout launches were limited, and conversations often failed to turn into orders.
Special Report
Apr.12
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
British American Tobacco (BAT) shares rose sharply on May 12 after the U.S. Food and Drug Administration signaled it would deprioritize enforcement against certain unauthorized e-cigarette and nicotine pouch products with accepted premarket applications. Investors viewed the move as favoring established players such as BAT’s Vuse and Velo brands.
BAT
May.13
From myblu to Zone: Imperial Brands Refocuses NGP Strategy in HY26
From myblu to Zone: Imperial Brands Refocuses NGP Strategy in HY26
mperial Brands’ HY26 results point to a more selective NGP transition. The company is using cash flow from traditional tobacco to fund targeted investments in modern oral nicotine, heated tobacco and reusable vaping systems. Its decision to exit the legacy myblu vaping business in the U.S., while expanding Zone nicotine pouches. In Europe, Imperial’s NGP growth is being driven by a multi-category portfolio including blu, Pulze and Zone/Skruf.
Special Report
May.12
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands said it will phase out its myblu vaping business in the United States, citing prolonged FDA approval timelines for new vape products. The company said it will instead focus on modern oral nicotine products in the U.S., including the expansion of its Zone brand and new flavors. While overall next-generation product revenue continued to grow, revenue from the category in the Americas declined sharply.
May.12
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA CTP issued a May 7 statement on accelerating product review and improving PMTA efficiency, but did not push it via official X and newsletter until May 13, one day after FDA Commissioner Marty Makary’s resignation was confirmed. FDA has not explained the delay, and no public evidence links it directly to the leadership change. The timing is notable given CTP’s usual 24-hour distribution practice.
Special Report
May.14
U.S. Adult Smoking Rate Falls to Historic Single-Digit Low of 9.9%, Study Shows Shift in Nicotine Use Patterns
U.S. Adult Smoking Rate Falls to Historic Single-Digit Low of 9.9%, Study Shows Shift in Nicotine Use Patterns
A new study analyzing National Health Interview Survey data found that adult cigarette smoking in the United States declined to 9.9% in 2024, down from 10.8% in 2023. The findings, published in NEJM Evidence, represent a historic milestone in U.S. tobacco control efforts. Researchers noted that while cigarette smoking is decreasing, the prevalence of e-cigarette and cigar use remained largely unchanged, suggesting a shift in nicotine consumption rather than the elimination of tobacco use.
Market
Mar.20